New facets of antifungal therapy
Related Experiment Video
Updated: Mar 12, 2026

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
Published on: February 14, 2018
Ya-Lin Chang1, Shang-Jie Yu1, Joseph Heitman2
1a Department of Plant Pathology and Microbiology , National Taiwan University , Taipei , Taiwan.
Abstract:
Invasive fungal infections remain a major cause of morbidity and mortality in immunocompromised patients, and such infections are a substantial burden to healthcare systems around the world. However, the clinically available armamentarium for invasive fungal diseases is limited to 3 main classes (i.e., polyenes, triazoles, and echinocandins), and each has defined limitations related to spectrum of activity, development of resistance, and toxicity. Further, current antifungal therapies are hampered by limited clinical efficacy, high rates of toxicity, and significant variability in pharmacokinetic properties. New antifungal agents, new formulations, and novel combination regimens may improve the care of patients in the future by providing improved strategies to combat challenges associated with currently available antifungal agents. Likewise, therapeutic drug monitoring may be helpful, but its present use remains controversial due to the lack of available data. This article discusses new facets of antifungal therapy with a focus on new antifungal formulations and the synergistic effects between drugs used in combination therapy.
Insights
New antifungal therapies, including novel formulations and combination treatments, offer hope for improving outcomes in invasive fungal infections, addressing limitations of current options.
Area of Science:
- Infectious Diseases
- Pharmacology
- Mycology
Background:
- Invasive fungal infections (IFIs) are a significant cause of illness and death in immunocompromised individuals.
- Current antifungal treatments (polyenes, triazoles, echinocandins) have limitations including narrow spectrum, resistance, and toxicity.
- Existing therapies often suffer from poor clinical efficacy and variable pharmacokinetic properties.
Purpose of the Study:
- To review advancements in antifungal therapy.
- To highlight new antifungal formulations and their potential benefits.
- To explore the synergistic effects of combination antifungal drug regimens.
Main Methods:
- Literature review of current and emerging antifungal strategies.
- Discussion of novel antifungal agents and formulations.
- Analysis of combination therapy principles and synergistic interactions.
Main Results:
- New antifungal agents and formulations are under development to overcome limitations of existing drugs.
- Combination therapies show promise for enhanced efficacy and broader spectrum of activity.
- Therapeutic drug monitoring for antifungals may offer benefits but requires further data.
Conclusions:
- Novel antifungal formulations and combination regimens are crucial for improving patient care.
- Addressing limitations of current antifungals requires continued research into new therapeutic approaches.
- Future strategies may involve personalized medicine and optimized drug combinations for invasive fungal diseases.
Related Concept Videos
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Fungal Phylum Microsporidia
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Drug Therapy
Antianxiety Medications
Antimicrobial Effectiveness
Overview of Fungi

